Schedule 13D ownership disclosure

Kindred Biosciences, Inc.

Security class unavailable · CUSIP: 494577109

Event date: 2021-06-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,846,657
Percent of class
15.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-085740
Form type
SC 13D
Filer
Elanco Animal Health Inc
CIK
CIK 1739104
Filed
Jun 25, 2021
Reporting period
Jun 15, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub